Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CareDx, Inc. - Common Stock (NQ:CDNA)

43.71 +5.61 (+14.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Why CareDx Stock Jumped Today ↗
The diagnostics leader is accelerating the trend toward precision medicine. 
Via The Motley Fool
News headline image
CareDx Q2 Earnings Call Highlights ↗
CareDx (NASDAQ:CDNA) reported second-quarter 2026 revenue growth of 52% as the transplant diagnostics company expanded testing services, completed the sale of its lab products business and began... 
Via MarketBeat
Topics Earnings
What's going on in today's session ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
CareDx (NASDAQ:CDNA) Passes Both the Minervini Trend Template and High Growth Momentum Tests ↗
Via Chartmill
CAREDX INC (NASDAQ:CDNA) Shows Perfect Minervini Trend Template and High Growth Momentum Setup ↗
Via Chartmill
CareDx (NASDAQ:CDNA) Beats Q1 Estimates and Raises Full-Year Guidance, But Stock Slips ↗
Via Chartmill
CareDx Inc (NASDAQ:CDNA) Reports Strong Revenue Beat but Profitability Concerns Weigh on Shares ↗
Via Chartmill
News headline image
CareDx's CEO Sells 17K Shares ↗
CareDx, a leader in transplant diagnostics, saw a key insider reduce his direct holdings amid a series of scheduled transactions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans ↗
CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted... 
Via MarketBeat
Topics Intellectual Property
News headline image
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies ↗
CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing... 
Via MarketBeat
News headline image
CareDx (CDNA) Q1 2026 Earnings Call Transcript ↗
CareDx (CDNA) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Via Chartmill
News headline image
CareDx (CDNA) Q2 2025 Earnings Transcript ↗
CareDx (CDNA) Q2 2025 Earnings Transcript 
Via The Motley Fool
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
CareDx (CDNA) Q4 2025 Earnings Call Transcript ↗
CareDx (CDNA) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
4 Analysts Assess CareDx: What You Need To Know ↗
 
Via Benzinga
News headline image
Power Solutions Stock Up 140% as $6.36 Million Exit Follows 62% Sales Surge ↗
Power Solutions International designs and manufactures advanced engines and power systems for industrial and transportation markets. 
Via The Motley Fool
Topics Energy Regulatory Compliance
News headline image
Freshworks Falls 60% in a Year as $7.5 Million Sale Shrinks Stake to 3.1% of This Portfolio's Assets ↗
This SaaS firm delivers cloud-based business software worldwide, focusing on subscription-driven customer and IT service solutions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Air Lease Stock Up 43% as Investor Trims $6.9 Million Stake Despite $1 Billion Profit Year ↗
Air Lease Corporation provides global airlines with commercial jet leasing, sales, and fleet management services across a diverse portfolio. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Five9 Stock Down 60% This Past Year, but One Investor Just Lifted Stake With $3.5 Million Buy ↗
Five9 delivers cloud-based contact center software for enterprises, serving clients across finance, healthcare, and technology sectors. 
Via The Motley Fool
News headline image
Freshworks Stock Down 60% in One Year as Revenue Jumps 16% and One Investor Sells $7 Million in Shares ↗
Freshworks delivers cloud-based SaaS solutions for customer engagement, IT service management, and business process automation. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 ↗
The CEO of this leading medical diagnostic company sold shares throughout multiple days in January. But the manner in which the shares were sold shouldn't concern investors. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CareDx President and CEO Sells 19,000 Shares for $412,000 ↗
This transplant diagnostics specialist saw a notable insider sale amid a year of modest share price decline and ongoing product innovation. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Analysts Have This To Say About CareDx ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
What's going on in today's after hours session ↗
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential ↗
CareDx, Inc. faces uncertainty with proposed reimbursement changes, but has long-term potential in the $8 billion transplant solutions market. 
Via Benzinga
News headline image
This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.